Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Strongbridge Bio Ord (SBBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Strongbridge Biopharma plc to Present at the JMP Securities Life Sciences Conference

Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc to Present at the Jefferies 2018 Global Healthcare Conference

Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)
A Peek Into Latest 13-F Filing: Top Hedge Fund Stocks

Top hedge fund stocks center around the technology, media and Internet sectors. Let's take a look at them.

NFLX : 391.98 (-0.23%)
GOOGL : 1,159.27 (-0.07%)
AAPL : 188.84 (-1.03%)
RTRX : 28.81 (+3.30%)
MSFT : 100.13 (-1.27%)
P : 7.97 (-0.99%)
TWX : 98.77 (unch)
GHDX : 49.59 (+0.65%)
ADBE : 251.82 (-2.43%)
SBBP : 6.85 (+6.20%)
FB : 195.85 (-0.49%)
PCRX : 37.65 (-2.08%)
AMZN : 1,715.97 (-0.46%)
ZGNX : 45.00 (+0.45%)
Strongbridge Biopharma plc Reports First Quarter 2018 Financial Results and Provides Corporate Update

~ KEVEYIS (dichlorphenamide) First Quarter 2018 Revenue of $3.9 Million ~

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc Announces New Employment Inducement Awards

Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc to Host First Quarter 2018 Financial Results Conference Call on May 10, 2018

Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc Announces Dosing of First Four Patients in LOGICS, a Second Global Phase 3 Study of RECORLEV(TM) (levoketoconazole) in Endogenous Cushing's Syndrome

Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc to Host Investor and Analyst Day on April 5, 2018

Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma Announces Issuance of Patent for RECORLEV(TM) (levoketoconazole) for the Treatment of Cushing's Syndrome

Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc Announces Presentation of New Data Demonstrating That Levoketoconazole is a Potent Inhibitor of Human Enzymes Controlling Cortisol Synthesis

~ Data Suggest Levoketoconazole, the Isolated 2S,4R Enantiomer of Ketoconazole,

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 12, 2018 / Strongbridge Biopharma plc (NASDAQ: SBBP) will be discussing their earnings results in their Q4 Earnings Call to be held on March 12, 2018 at 8:30 AM Eastern...

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc to Present KEVEYIS(R) (dichlorphenamide) Primary Periodic Paralysis Data at the 2018 American Academy of Neurology Annual Meeting

~ Post-Hoc Analysis of Phase 3 Placebo-Controlled Study of KEVEYIS Showed Adolescents had Similar Improvements in Short-Term Attack Rates as Adults ~

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc to Host Conference Call on March 12, 2018 to Announce Fourth Quarter and Year-End 2017 Financial Results and Provide Corporate Update

Strongbridge Biopharma plc (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)
Stocks Take the Powell Plunge

Stocks Take the Powell Plunge

ENVA : 35.85 (+1.13%)
TOT : 60.59 (-1.00%)
INCY : 73.96 (+0.43%)
AEM : 45.14 (-3.13%)
SBBP : 6.85 (+6.20%)
KAR : 54.90 (-0.44%)
Strongbridge Biopharma plc Announces Underwriters' Partial Exercise of Option to Purchase Additional Shares

Strongbridge Biopharma plc (NASDAQ:SBBP) (the "Company") today announced that the underwriters of its previously announced underwritten public offering of 5,000,000 ordinary shares have partially exercised...

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc Announces Annual General Meeting of Shareholders

Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc Announces Proposed Public Offering of 5 Million Ordinary Shares

Strongbridge Biopharma plc (NASDAQ:SBBP) (the "Company") today announced that it intends to offer and sell 5 million of its ordinary shares in an underwritten public offering. The Company also intends...

SBBP : 6.85 (+6.20%)
Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Covering RECORLEV(TM) (levoketoconazole) for the Treatment of Cushing's Syndrome

Strongbridge Biopharma plc (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)
Aeterna Zentaris Enters into Licensing and Assignment Agreement with Strongbridge for Macrilen(TM) (macimorelin) in the U.S. and Canada

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced today that it has, through a wholly-owned subsidiary, entered into a license and assignment agreement with a wholly-owned subsidiary of Strongbridge...

AEZS.TO : 2.81 (+1.08%)
AEZS : 2.14 (+0.94%)
SBBP : 6.85 (+6.20%)
Strongbridge Biopharma plc Announces New Employment Inducement Awards

Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs,...

SBBP : 6.85 (+6.20%)

Van Meerten Stock Picks

5 Great Large Caps
This morning I wanted to find 5 Large Cap stocks that had performed well over the last year and still appeared to have some juice left in them.
ABMD +2.93 , NFLX -0.89 , VLO -1.64 , RL +0.62 , ALGN -3.61
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed with most nearby contracts 1 to 2 cents lower on Friday, despite showing gains at midday. Front month July lost 4.37% on the week. December fell to within 1 1/4 cents of the life of contract low in the overnight session. Managed m...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar